Two technologies recommended for people with chronic tic disorders and Tourette syndrome
Draft guidance issued for consultation recommends two technologies to help people manage their condition.
Draft guidance issued for consultation recommends two technologies to help people manage their condition.
Companies who receive scientific advice from our NICE Advice service may experience a faster path to guidance publication, a study has found.
The guideline makes new recommendations and updates existing ones on diagnosing and managing a condition that affects approximately 1.5 million women of reproductive age in the UK.
Our updated guideline on menopause emphasises the importance of an individualised approach and shared decision-making when making choices about treatment for symptoms.
How we make independent decisions on the cost and clinical effectiveness of medicines and treatments.
How Clatterbridge Cancer Centre improved early detection rates of metatstatic spinal cord compression, and increased the average survival rates of patients through following our recommendations.
5 ways NICE Advice can help you navigate this new opportunity alongside health technology assessment.
Our associate director of NICE Advice outlines his top tips for healthtech companies, helping them chart a clear path from innovation to NHS adoption.